Nuclear medicine communicationsHumansMaleProstatic NeoplasmsCastration-ResistantLutetium
Concordance between single-time-point and multiple-time-point dosimetry in 177 Lu-PSMA-I&T therapy for metastatic castration-resistant prostate cancer.
Nathaly Barbosa, Carlos Granados, Edwin Pulido, Clarena Zuluaga
Published: 202610.1097/MNM.0000000000002076
Abstract
PURPOSE: To quantify concordance between single-time-point (STP) and multiple-time-point (MTP) dosimetry for organs-at-risk (OARs) and lesions in 177 Lu-PSMA-I&T. METHODS: Thirteen men with metastatic castration-resistant prostate cancer underwent qu…
Preview only. Read the full abstract at the source